Consistent with this observation, further work revealed the loss of TβRIII to be associated with the development of an immunotolerant microenvironment characterized by a decrease in the number of CD8+ T cells and a corresponding increase in the CD4+FoxP3+ Treg population in both breast cancer and melanoma model systems. The gene discussed is FOXP3; the disease is melanoma.